Takeda appoints Serina Fischer as GM for India
02 March 2022 | News
Serina will lead the company's business in India, ensuring patient access to the company's highly innovative medicines
Takeda Pharmaceutical Company announced the appointment of Serina Fischer as its General Manager for India operations. The appointment is effective as of March 1, 2022. In her new role, Serina will lead the company's business in India, ensuring patient access to the company's highly innovative medicines.
Serina has over 17 years of experience in the biopharmaceutical industry and is an accomplished, dynamic leader with expertise in strategy, sales, marketing, and operations. She joined Takeda in 2017 and has held various leadership roles in its US affiliate.
